(19)
(11) EP 3 897 585 A1

(12)

(43) Date of publication:
27.10.2021 Bulletin 2021/43

(21) Application number: 18827093.8

(22) Date of filing: 20.12.2018
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
 A61K 31/58(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2031; A61K 9/2077; A61K 31/58
(86) International application number:
PCT/EP2018/086401
(87) International publication number:
WO 2020/126017 (25.06.2020 Gazette 2020/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicants:
  • Pharmaceutical Oriented Services Ltd
    14452 Metamorfossi Attikis (GR)
  • Remedica Ltd
    Limassol 3508 (CY)

(72) Inventors:
  • PANAGOPOULOS, Panagiotis
    14452 Metamorfossi Attikis (GR)
  • PANITSAS, Konstantinos-Emmanouil
    14452 Metamorfossi Attikis (GR)
  • ALEXAKI, Pandora
    14452 Metamorfossi Attikis (GR)
  • KANTAS, Dimosthenis
    14452 Metamorfossi Attikis (GR)
  • VACHRATIDIS, George
    14452 Metamorfossi Attikis (GR)
  • VOUVALIDIS, John
    14452 Metamorfossi Attikis (GR)
  • MICHALI, Christina
    14452 Metamorfossi Attikis (GR)
  • PATTIHIS, Charalambos
    3508 Limassol (CY)
  • NORDMANN, Antje
    3508 Limassol (CY)
  • NEOPTOLEMOU, Michalis
    3508 Limassol (CY)

(74) Representative: Hamm&Wittkopp Patentanwälte PartmbB 
Jungfernstieg 38
20354 Hamburg
20354 Hamburg (DE)

   


(54) DOSAGE FORM CONTAINING ABIRATERONE ACETATE